ICU Medical, Inc.
ICUI
Clasificación en acciones
#4006
ICU Medical, Inc., operating globally through its subsidiaries, is a medical... ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.
Precio por acción
$162.74
Última sincronización: 2026-10-16
Capitalización bursátil
$4.07B
Cambio (1 día)
-2.68%
Cambio (1 año)
37.38%
País
US
Comercio ICU Medical, Inc. (ICUI)
Categoría
Healthcare
EPS de ICU Medical, Inc. (ICUI)
EPS a fecha de June 2026 TTM: $1.20
Según los últimos informes financieros y el precio de las acciones de ICU Medical, Inc., el EPS actual de la empresa (TTM) es $1.20. Al final del año 2023, la empresa tenía un EPS de $-1.23 una disminución en comparación con al EPS de 2022, que fue de $-3.11.
Historial de EPS de ICU Medical, Inc. desde 2000 hasta 2026
EPS al final de cada año
| Año | EPS | Cambiar |
|---|---|---|
| 2026 (TTM) | $1.20 | -124.84% |
| 2024 | $-4.83 | 292.68% |
| 2023 | $-1.23 | -60.45% |
| 2022 | $-3.11 | -163.99% |
| 2021 | $4.86 | 16.83% |
| 2020 | $4.16 | -15.10% |
| 2019 | $4.90 | 268.42% |
| 2018 | $1.33 | -62.00% |
| 2017 | $3.50 | -10.26% |
| 2016 | $3.90 | 37.32% |
| 2015 | $2.84 | 65.12% |
| 2014 | $1.72 | -37.45% |
| 2013 | $2.75 | -5.17% |
| 2012 | $2.90 | -10.22% |
| 2011 | $3.23 | 46.82% |
| 2010 | $2.20 | 22.22% |
| 2009 | $1.80 | 4.65% |
| 2008 | $1.72 | 6.17% |
| 2007 | $1.62 | -8.99% |
| 2006 | $1.78 | 21.09% |
| 2005 | $1.47 | 297.30% |
| 2004 | $0.37 | -77.16% |
| 2003 | $1.62 | 13.29% |
| 2002 | $1.43 | 19.17% |
| 2001 | $1.20 | 26.32% |
| 2000 | $0.95 | 0.00% |
EPS de empresas similares o competidoras
| Empresa | EPS | Diferencia de EPS | País |
|---|---|---|---|
| $8.85 | 637.50% |
US
|
|
| $6.41 | 433.77% |
FR
|
|
| - | - |
JP
|
|
| $3.32 | 176.67% |
US
|
|
| - | - |
CH
|
